| Identification | Back Directory | [Name]
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl) pyridin-3-yl]purine | [CAS]
1612191-99-7 | [Synonyms]
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl) pyridin-3-yl]purine
9-(3'-Deoxy-3'-fluoro-b-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl)pyridin-3-yl]purine
9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl) pyridin-3-yl]purine
9H-Purine, 9-(3-deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]- | [Molecular Formula]
C20H24FN7O3 | [MDL Number]
MFCD29915408 | [MOL File]
1612191-99-7.mol | [Molecular Weight]
429.46 |
| Hazard Information | Back Directory | [Uses]
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl) pyridin-3-yl]purine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList1701258/0_EN.htm |
|